Contineum Therapeutics (CTNM) Ending Cash Balance (2023 - 2026)
Contineum Therapeutics' Ending Cash Balance was $75.2 million in Q3 2026, up 76.4% from $42.63 million a year earlier and up 411.2% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Ending Cash Balance (2023 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Contineum Therapeutics came in at $75.6 million, up 244.5% from FY2024.
- In earlier years, Ending Cash Balance was $21.94 million in FY2024 (+41.3%) and $15.53 million in FY2023.
- Quarterly Ending Cash Balance has moved between $9.06 million (Q1 2023) and $77.23 million (Q2 2024) over five years.
- Compared with a year earlier, Ending Cash Balance was higher in five of the last eight quarters, with growth averaging 36.5%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q4 2025 (growth of 244.5%); the worst was Q2 2025 (a decline of 73.1%).
- Per Business Quant data, CTNM's Ending Cash Balance in the three quarters before Q3 2026 was $14.71 million (Q2 2026), $20.16 million (Q1 2026) and $75.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 75.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 75.20 Mn |
| Jun 30, 2026 | 14.71 Mn |
| Mar 31, 2026 | 20.16 Mn |
| Dec 31, 2025 | 75.60 Mn |
| Sep 30, 2025 | 42.63 Mn |
| Jun 30, 2025 | 20.78 Mn |
| Mar 31, 2025 | 22.47 Mn |
| Dec 31, 2024 | 21.94 Mn |
| Sep 30, 2024 | 40.89 Mn |
| Jun 30, 2024 | 77.23 Mn |
| Mar 31, 2024 | 16.26 Mn |
| Dec 31, 2023 | 15.53 Mn |
| Sep 30, 2023 | 17.52 Mn |
| Jun 30, 2023 | 52.07 Mn |
| Mar 31, 2023 | 9.06 Mn |
API Access
Contineum Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();